Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2

Penglei Wang(North University of China), Kangdong Liu(Zhengzhou University), Yamei Hu(Zhengzhou University), Bingbing Lu(Zhengzhou University), Cong Peng(Central South University), Dengyun Zhao(Zhengzhou University), Wenna Nie(China-US (Henan) Hormel Cancer Institute), Lingwei Zhang(Zhengzhou University), Zigang Dong(China-US (Henan) Hormel Cancer Institute), Tingting Liu(State Administration of Traditional Chinese Medicine of the People's Republic of China), Pan Li(Dalian Medical University), Jialin Liu(Beijing Proteome Research Center), Xuejiao Liu(Xuzhou Medical College), Xuechao Jia(Zhengzhou University), Ruihua Bai(Institute of Soil and Water Conservation), Han Huang(Zhengzhou University), Yanan Jiang(Zhengzhou University), Xinli Ma(Northwest A&F University), Huifang Wei(Ningbo University of Technology), Yan Qiao(Hunan University), Xueli Tian(Zhengzhou University), Qiong Wu(Zhengzhou University)
Signal Transduction and Targeted Therapy
March 6, 2023
Cited by 93


Related Papers